Transcriptional expressions of hsa-mir-183 predicted target genes as independent indicators for prognosis in bladder urothelial carcinoma
Figure 10. Gene mutations of predicted target genes (PDCD6, GNG5, PHF6, MAL2, SLC25A15, PTDSS1) and their association with OS and PFS in BLCA patients (A: Genetic alterations; B: Overall survival; C: Progress free survival).